A new study from Cedars-Sinai Cancer and the University of Colorado Anschutz Medical Campus reveals a potential way to overcome tumor resistance to a common chemotherapy drug called cisplatin.
A new study from Cedars-Sinai Cancer and the University of Colorado Anschutz Medical Campus reveals a potential way to overcome tumor resistance to a common chemotherapy drug called cisplatin.